MYCN and neuroblastoma: Mechanistic studies have shown that HHT interferes with the binding of N-Myc to the INSM1 promoter, inhibits PI3K/AKT-mediated N-Myc stability, and helps inhibit the growth of NB tumor cells (Chen et al., 2023).